The influence of prehabilitation in patients with liver cirrhosis before liver transplantation: a randomized clinical trial

被引:2
|
作者
Skladany, Lubomir [1 ,2 ]
Liska, David [3 ,7 ]
Gurin, Daniel [4 ]
Molcan, Pavol [1 ]
Bednar, Roman [5 ]
Vnencakova, Janka [1 ]
Koller, Tomas [6 ]
机构
[1] Slovak Med Univ, FD Roosevelt Teaching Hosp, Fac Med, Dept Internal Med 2,Div Hepatol Gastroenterol & Li, Banska Bystrica, Slovakia
[2] Safarik Univ, Fac Med, Dept Internal Med 2, Kosice, Slovakia
[3] Matej Bel Univ, Fac Arts, Dept Phys Educ & Sports, Banska Bystrica, Slovakia
[4] Slovak Med Univ Bratislava, Fac Healthcare, Banska Bystrica, Slovakia
[5] Slovak Med Univ, FD Roosevelt Teaching Hosp, Dept Physiatry Balneol & Rehabil, Banska Bystrica, Slovakia
[6] Univ Hosp, Comenius Univ, Fac Med, Dept Internal Med 5,Subdiv Gastroenterol & Hepatol, Bratislava, Slovakia
[7] Matej Bel Univ, Fac Arts, Tajovskeho 40, Banska Bystrica 97401, Slovakia
关键词
Prehabilitation; Exercise; Frailty; Liver transplantation; PHYSICAL-ACTIVITY; MUSCLE MASS; SARCOPENIA; FRAILTY; EXERCISE; MODEL;
D O I
10.23736/S1973-9087.23.08130-3
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
BACKGROUND: The high prevalence of liver cirrhosis in Slovakia leads to a great need for transplant treatment. The outcome of liver transplantation is influenced by several factors. AIM: The main objective of this study is to test the effectiveness of prehabilitation compared to standard of care. DESIGN: Prospective, double-arm, randomized, open-registry study. SETTING: Patient in F. D. Roosevelt Teaching Hospital, Slovakia, Banska Bystrica. POPULATION: The participants consisted of patients with liver cirrhosis (55 men, 25 women). METHODS: The patients were randomized to the active prehabilitation group (N.=39) or the standard of care group (SOC) (N.=41). SOC represents the standard of care for patients prior to liver transplantation, consisting of a formal oral interview lasting 30 minutes. In addition to SOC, each patient with decompensated liver cirrhosis also underwent a prehabilitation intervention that included rehabilitation and nutrition support. Patients completed the exercises under the supervision of a physician during hospitalisation. RESULTS: After one month, the liver frailty index improved in the prehabilitation group (P=0.05). No improvement in MELD (Model of End Stage Liver Disease) was found in the group that underwent the prehabilitation program (P=0.28), and no improvement was found in the Child-Pugh score after one month (P=0.13). In the prehabilitation groups compared with the SOC group, differences were not found in the MELD score (P=0.11). Better clinical outcomes according to the ChildPugh score was found for the prehabilitation group compared with the SOC group (P=0.02). According to LFI, there was no difference between the groups (P=0.26). Very low adherence was found after three months. Only three patients in the SOC group and six patients in the prehabilitation group came to the check-up. Due to low adherence after 3 months in patients with liver cirrhosis, it is not possible to make an adequate comparison between groups after three months. CONCLUSIONS: Despite the great effort to maintain adherence, it was not possible to draw a conclusion about the effectiveness of prehabilitation in patients before liver transplantation compared to standard of care because the main problem in Slovak patients with liver cirrhosis is low adherence. More studies are needed to identify the barriers that lead to low adherence in patients with liver cirrhosis. CLINICAL REHABILITATION IMPACT: A promising result was found due to improvement of the Liver Frailty Index and the Child-Pugh Score after one month in the prehabilitation group.
引用
收藏
页码:122 / 129
页数:8
相关论文
共 50 条
  • [21] Liver transplantation of patients with cryptogenic cirrhosis: Clinical characteristics and outcome
    Marmur, Joel
    Bergquist, Annika
    Stal, Per
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, 45 (01) : 60 - 69
  • [22] Sarcopenia in cirrhosis before living donor liver transplantation
    Acar, S.
    Gencdal, G.
    Alkara, U.
    Eren, E.
    Topac, M.
    Tellioglu, G.
    Dinckan, A.
    Akyildiz, M.
    TRANSPLANTATION, 2018, 102 : 131 - 131
  • [23] Serum sterols in patients with primary biliary cirrhosis and acute liver failure before and after liver transplantation
    Nikkila, Katriina
    Nissinen, Markku J.
    Gylllng, Helena
    Isonlemi, Helena
    Miettinen, Tatu A.
    JOURNAL OF HEPATOLOGY, 2008, 49 (06) : 936 - 945
  • [24] Liver transplantation for patients with alcoholic cirrhosis
    Fabrega, F
    Foster, PF
    Sankary, HN
    Karademir, S
    Kociss, K
    McChesney, LP
    Williams, JW
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 465 - 466
  • [25] Heart transplantation in patients with liver cirrhosis
    Hsu, Ron-Bin
    Chang, Chung-I
    Lin, Fang-Yue
    Chou, Nai-Kuan
    Chi, Nai-Hsin
    Wang, Shoei-Shen
    Chu, Shu-Hsun
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2008, 34 (02) : 307 - 312
  • [26] Gastrointestinal symptoms in patients with cirrhosis: a longitudinal study before and after liver transplantation
    Kalaitzakis, Evangelos
    Josefsson, Axel
    Castedal, Maria
    Henfridsson, Pia
    Bengtsson, Maria
    Andersson, Bengt
    Bjornsson, Einar
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2013, 48 (11) : 1308 - 1316
  • [27] Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma
    Herrero, JI
    Sangro, B
    Quiroga, J
    Pardo, F
    Herraiz, M
    Cienfuegos, JA
    Prieto, J
    LIVER TRANSPLANTATION, 2001, 7 (07) : 631 - 636
  • [28] Response to exercise in patients with liver cirrhosis: Implications for liver transplantation
    Lemyze, Malcolm
    Dharancy, Sebastien
    Wallaert, Benoit
    DIGESTIVE AND LIVER DISEASE, 2013, 45 (05) : 362 - 366
  • [29] Safety and efficacy of risedronate for patients with esophageal varices and liver cirrhosis: a non-randomized clinical trial
    Lima, Talles Bazeia
    Amaral Santos, Livia Alves
    de Carvalho Nunes, Helio Rubens
    Silva, Giovanni Faria
    Caramori, Carlos Antonio
    Qi, Xingshun
    Romeiro, Fernando Gomes
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [30] Safety and efficacy of risedronate for patients with esophageal varices and liver cirrhosis: a non-randomized clinical trial
    Talles Bazeia Lima
    Lívia Alves Amaral Santos
    Hélio Rubens de Carvalho Nunes
    Giovanni Faria Silva
    Carlos Antonio Caramori
    Xingshun Qi
    Fernando Gomes Romeiro
    Scientific Reports, 9